Recall Register

Device recall: Novocastra Liquid Mouse Monoclonal Antibody Calretinin, NCL-L-CALRET-566. Intended for the qualitative identification…

Class II FDA enforcement event 73823. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Novocastra Liquid Mouse Monoclonal Antibody Calretinin when used in combination with specific Lots of antibody diluent will give reduced staining.

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Leica Microsystems, Inc. started this device recall on 22 Mar 2016. The firm address in the FDA record is in Buffalo Grove, IL. FDA put the recall in Class II. FDA event 73823 has 1 product record. The first FDA enforcement report date is 1 Jun 2016. The record gives the status Terminated, with the termination date 30 Nov 2017.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide Distribution -- U.S., to the following states: AK, CA, FL, GA, MN, MT, NJ, OH, TX and WA; and, the country of Canada.

Recalling firm

Leica Microsystems, Inc., Buffalo Grove, IL.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 73823: product records
Recall numberProductQuantityClassStatusReport date
Z-1704-2016Novocastra Liquid Mouse Monoclonal Antibody Calretinin, NCL-L-CALRET-566. Intended for the qualitative identification by light microscopy of human calretinin molecule in paraffin sections.290 unitsClass IITerminated1 Jun 2016

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2016
1,232
Share of these events in Class II
91%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
33

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 73823. https://recallregister.com/fda/ii/73823/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide Distribution -- U.S., to the following states: AK, CA, FL, GA, MN, MT, NJ, OH, TX and WA; and, the country of Canada.
What quantity of product is in FDA event 73823?
The FDA record gives this quantity: 290 units
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2016 have the same class?
91% of the 1,232 device events that started in 2016 are in Class II.